By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Business information firm Thomson Reuters has bought GeneGo for an undisclosed sum in order to expand its healthcare and life sciences portfolio.

GeneGo, which provides bioinformatics tools for use in drug target selection and validation, biomarker identification, and patient profiling, has become part of Thomson Reuters' Healthcare & Science business segment.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A lack of funding may lead more than two dozen research facilities in Australia to shut down in three months.

Researchers report that paternally inherited genes are more likely to be expressed in mice.

In Genome Research this week: multiplex genotyping of germline and somatic short tandem repeats, graph-based regularization, and more.

In PNAS this week: Akt3 amplification in glioma progression, Tibetan Plateau frog genome, and more.